Literature DB >> 8946863

An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.

K Y Look1, V L Brunetto, D L Clarke-Pearson, H E Averette, F J Major, R D Alvarez, H D Homesley, R J Zaino.   

Abstract

The influence of cell type on recurrence-free interval (RFI) and survival after radical hysterectomy for patients with Stage IB carcinoma of the cervix was investigated. Patients with Stage IB carcinoma of the cervix (>3-mm invasion) underwent a radical hysterectomy and pelvic lymphadenectomy. Patients with involved paraaortic nodes or gross extracervical disease were excluded. Of 813 evaluable patients, 645 had squamous, 104 with adenocarcinoma, and 64 had adenosquamous cell type. The time to failure and the following clinical/pathologic characteristics were compared among the three cell types: age, Gynecologic Oncology Group performance status (PS), gross versus occult tumor, histologic grade, depth of invasion, node status, uterine extension, parametrial extension, surgical margins, and capillary-lymphatic space (CLS) involvement. A Cox proportional hazards model was used to compare the patients with adenosquamous and adenocarcinoma to those with squamous while adjusting for prognostic factors. The median age was 40 years (range, 21-87). Pelvic nodes were involved in 119 (15%) of patients. There were no significant differences between cell types in distributions of the following factors: age, PS, positive nodes, depth of invasion, uterine extension, surgical margins, or parametrial extension. There were statistically significant differences between cell types with regards to grade (P < 0.001), gross versus occult primary status (P = 0.016), and CLS involvement (P = 0.005). There was no statistically significant difference detected between cell types in crude comparisons of RFI (P = 0.29); however, there was a difference in survival (P = 0.02) with shorter survival seen in the adenosquamous cell type. After adjusting for CLS involvement, PS, depth of invasion, and clinical tumor size, survival remained worse for patients with adenosquamous primaries when compared to squamous carcinoma (P = 0.02) and adenocarcinoma (P = 0.007). In conclusion, no statistically significant differences were seen in RFI among cell types; however, in patients with Stage I carcinoma of the cervix overall survival after radical hysterectomy may be slightly worse for those with adenosquamous cell type.

Entities:  

Mesh:

Year:  1996        PMID: 8946863     DOI: 10.1006/gyno.1996.0327

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  24 in total

1.  Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer.

Authors:  Beatrice Cormier; John P Diaz; Karin Shih; Rachael M Sampson; Yukio Sonoda; Kay J Park; Khaled Alektiar; Dennis S Chi; Richard R Barakat; Nadeem R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2011-05-13       Impact factor: 5.482

2.  Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with 18F-fluorodeoxyglucose-positron emission tomography in stage IB cervical cancer.

Authors:  Alexander J Lin; Jason D Wright; Farrokh Dehdashti; Barry A Siegel; Stephanie Markovina; Julie Schwarz; Premal H Thaker; David G Mutch; Matthew A Powell; Perry W Grigsby
Journal:  Int J Gynecol Cancer       Date:  2019-08-30       Impact factor: 3.437

3.  Apoptosis Phenomena in Squamous Cell Carcinomas and Adenocarcinomas of the Uterine Cervix.

Authors:  Mariana Gamba De Paula Eduardo; Adriana Bittencourt Campaner; Maria Antonieta Longo Galvão Silva
Journal:  Pathol Oncol Res       Date:  2015-02-15       Impact factor: 3.201

4.  HPV16 variant lineage, clinical stage, and survival in women with invasive cervical cancer.

Authors:  Rosemary E Zuna; Erin Tuller; Nicolas Wentzensen; Cara Mathews; Richard A Allen; Rebecca Shanesmith; S Terence Dunn; Michael A Gold; Sophia S Wang; Joan Walker; Mark Schiffman
Journal:  Infect Agent Cancer       Date:  2011-10-28       Impact factor: 2.965

5.  A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.

Authors:  Xiuzhen Xie; Kun Song; Baoxia Cui; Jie Jiang; Xingsheng Yang; Beihua Kong
Journal:  Int J Clin Oncol       Date:  2018-01-03       Impact factor: 3.402

6.  Long-Term Oncologic Outcomes of Uterine-Preserving Surgery in Young Women With Stage Ib1 Cervical Cancer.

Authors:  Jill H Tseng; Alessia Aloisi; Yukio Sonoda; Ginger J Gardner; Oliver Zivanovic; Nadeem R Abu-Rustum; Mario M Leitao
Journal:  Int J Gynecol Cancer       Date:  2018-09       Impact factor: 3.437

7.  Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix.

Authors:  J-Y Park; D-Y Kim; J-H Kim; Y-M Kim; Y-T Kim; J-H Nam
Journal:  Br J Cancer       Date:  2010-06-08       Impact factor: 7.640

8.  Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival.

Authors:  Jill H Tseng; Alessia Aloisi; Yukio Sonoda; Ginger J Gardner; Oliver Zivanovic; Nadeem R Abu-Rustum; Mario M Leitao
Journal:  Gynecol Oncol       Date:  2018-07       Impact factor: 5.482

9.  Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix.

Authors:  T Kasamatsu; T Onda; M Sawada; T Kato; S Ikeda; Y Sasajima; H Tsuda
Journal:  Br J Cancer       Date:  2009-05-05       Impact factor: 7.640

10.  Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy.

Authors:  Tatsuya Kato; Hidemichi Watari; Mahito Takeda; Masayoshi Hosaka; Takashi Mitamura; Noriko Kobayashi; Satoko Sudo; Masanori Kaneuchi; Masataka Kudo; Noriaki Sakuragi
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.